J&J-Guidant Merger Spotlights Stent Patent Wars
Johnson & Johnson's pending $21.5 billion acquisition of Guidant, one of the largest mergers in the history of the medical device industry, puts the spotlight on the intense legal battle over...To view the full article, register now.
Already a subscriber? Click here to view full article